Get started
Award

108419

Funded outputs count: 53
Funder award ID: 108419
OpenAlex ID: G2625872114
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
2026 · Billaud, Amandine, Figlioli, Gisella, et al. · Apollo (University of Cambridge)
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
2025 · Amandine Billaud, Gisella Figlioli, et al. · The Breast · 2
PDF
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
2025 · Maria Zanti, Denise G. O’Mahony, et al. · Nature Communications · 11
PDF
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
2024 · Figueroa, J., Lee, D.G., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
Combined Associations of a Polygenic Risk Score and Classical Risk Factors with Breast Cancer Risk
2024 · Mavaddat, N., Schoemaker, M.J., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer
2023 · Katharina Wichert, Reiner Hoppe, et al. · European Journal of Epidemiology · 8
PDF
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
2023 · Maria Zanti, Denise G. O'Mahony, et al. · Human Mutation · 6
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
2023 · Pooja Middha, Xiaoliang Wang, et al. · Breast Cancer Research · 13
PDF
Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
2023 · Anna Morra, Maartje A. C. Schreurs, et al. · Cancer Medicine · 11
PDF
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases
2023 · Gisella Figlioli, Amandine Billaud, et al. · Cancers · 1
PDF
The impact of coding germline variants on contralateral breast cancer risk and survival
2023 · Anna Morra, Nasim Mavaddat, et al. · The American Journal of Human Genetics · 26
PDF
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
2023 · Gisella Figlioli, Amandine Billaud, et al. · European Journal of Human Genetics · 15
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023 · Josephine M.N. Lopes Cardozo, Irene L. Andrulis, et al. · Journal of Clinical Oncology · 28
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
2022 · Isabelle Grootes, Renske Keeman, et al. · European Journal of Cancer · 20
PDF
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
2022 · Xiaoliang Wang, Pooja Middha Kapoor, et al. · Scientific Reports · 6
PDF
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
2022 · Nasim Mavaddat, Leila Dorling, et al. · JAMA Oncology · 169
PDF
Rare germline copy number variants (CNVs) and breast cancer risk
2022 · Joe Dennis, Jonathan P. Tyrer, et al. · Communications Biology · 15
PDF
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
2021 · Maria Escala-Garcia, Sander Canisius, et al. · Scientific Reports · 5
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2021 · Anna Morra, Maria Escala-Garcia, et al. · Breast Cancer Research · 22
PDF
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
2021 · Hanla A. Park, Sonja Neumeyer, et al. · British Journal of Cancer · 22
PDF
Genome-Wide Interaction Analysis of Menopausal Hormone Therapy Use and Breast Cancer Risk Among 62,370 Women
2021 · Xiaoliang Wang, Pooja Middha Kapoor, et al. · Research Square · 1
PDF
Rare copy number variants (CNVs) and breast cancer risk
2021 · Joe Dennis, Jonathan P. Tyrer, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
2021 · JooYong Park, Ji-Yeob Choi, et al. · Cancers · 9
PDF
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
2021 · Juliette Coignard, Michael Lush, et al. · Nature Communications · 40
PDF
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
2021 · NBCS Collaborators, Nichola Johnson, et al. · British Journal of Cancer · 9
Year
Topic